X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
index medicus (22) 22
female (20) 20
oncology (20) 20
article (15) 15
cancer (15) 15
breast cancer (13) 13
cell line, tumor (13) 13
animals (12) 12
breast neoplasms - metabolism (10) 10
immunohistochemistry (10) 10
pathology (9) 9
protein expression (9) 9
biomarkers, tumor - analysis (8) 8
gene expression (8) 8
mice (8) 8
middle aged (8) 8
biomarkers (7) 7
breast neoplasms - pathology (7) 7
estrogen-receptor (7) 7
tumors (7) 7
breast neoplasms - drug therapy (6) 6
immunotherapy (6) 6
medicine, research & experimental (6) 6
prognosis (6) 6
tissue microarrays (6) 6
treatment outcome (6) 6
adult (5) 5
breast neoplasms - genetics (5) 5
disease models, animal (5) 5
endocrine therapy (5) 5
expression (5) 5
inhibition (5) 5
lymphocytes (5) 5
shows (5) 5
tamoxifen (5) 5
tissue array analysis (5) 5
transcription (5) 5
triple negative breast neoplasms - drug therapy (5) 5
triple negative breast neoplasms - pathology (5) 5
breast (4) 4
cancer biology (4) 4
carcinoma (4) 4
cell biology (4) 4
estrogen receptor alpha - genetics (4) 4
estrogen receptors (4) 4
fulvestrant (4) 4
gene amplification (4) 4
health aspects (4) 4
immunohistochemistry - methods (4) 4
mutation (4) 4
neoadjuvant chemotherapy (4) 4
patients (4) 4
phenotype (4) 4
predictive value of tests (4) 4
receptors, estrogen - analysis (4) 4
signal transduction - drug effects (4) 4
triple negative breast neoplasms - genetics (4) 4
triple negative breast neoplasms - metabolism (4) 4
tumor-infiltrating (4) 4
xenografts (4) 4
activation (3) 3
aged (3) 3
analysis (3) 3
analysis aqua (3) 3
antineoplastic agents - therapeutic use (3) 3
apoptosis (3) 3
biology (3) 3
biomarkers, tumor - biosynthesis (3) 3
breast neoplasms - chemistry (3) 3
breast neoplasms - mortality (3) 3
cell lines (3) 3
chemotherapy (3) 3
cohort studies (3) 3
drug resistance, neoplasm (3) 3
egfr (3) 3
estrogen (3) 3
estrogen receptor (3) 3
estrogen receptor alpha - metabolism (3) 3
experimental design (3) 3
gene expression regulation, neoplastic (3) 3
genes (3) 3
genetic aspects (3) 3
immunohistochemistry - standards (3) 3
inhibitors (3) 3
ligands (3) 3
medicine (3) 3
metastasis (3) 3
postmenopausal women (3) 3
proportional hazards models (3) 3
protein (3) 3
protein kinase inhibitors - pharmacology (3) 3
quantitative-analysis (3) 3
receptor, epidermal growth factor - analysis (3) 3
receptor, erbb-2 - analysis (3) 3
receptor, erbb-2 - metabolism (3) 3
receptors, estrogen - biosynthesis (3) 3
receptors, estrogen - metabolism (3) 3
receptors, progesterone - analysis (3) 3
sensitivity and specificity (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Laboratory Investigation, ISSN 0023-6837, 10/2017, Volume 97, Issue 10, pp. 1263 - 1263
Journal Article
eLife, 05/2019, Volume 8
Squamous cell carcinomas (SCCs) account for the majority of cancer mortalities. Although TP63 is an established lineage-survival oncogene in SCCs, therapeutic... 
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7693, pp. 544 - 548
Therapeutic antibodies that block the programmed death-1 (PD-1)-programmed death-ligand 1 (PD-L1) pathway can induce robust and durable responses in patients... 
METASTATIC MELANOMA | CTLA-4 BLOCKADE | BLADDER-CANCER | THERAPY | LANDSCAPE | SUBTYPES | UROTHELIAL CARCINOMA | MULTIDISCIPLINARY SCIENCES | GENES | ADAPTIVE IMMUNE RESISTANCE | MPDL3280A | CD8-Positive T-Lymphocytes - cytology | Humans | Antibodies, Monoclonal - therapeutic use | Urothelium - pathology | Urologic Neoplasms - pathology | Neoplasm Metastasis | Urologic Neoplasms - drug therapy | Urologic Neoplasms - genetics | Immunotherapy | Antibodies - immunology | Antigens, Neoplasm - metabolism | Transforming Growth Factor beta - antagonists & inhibitors | Antigens, Neoplasm - analysis | Disease Models, Animal | Fibroblasts - metabolism | Antibodies - therapeutic use | Antigens, Neoplasm - immunology | Antibodies, Monoclonal - pharmacology | Treatment Outcome | B7-H1 Antigen - immunology | Urologic Neoplasms - immunology | Antibodies - pharmacology | Tumor Microenvironment - immunology | Collagen - metabolism | Phenotype | Animals | B7-H1 Antigen - antagonists & inhibitors | Signal Transduction - drug effects | Cell Cycle Checkpoints - drug effects | CD8-Positive T-Lymphocytes - drug effects | Urothelium - immunology | Mice | Mutation | CD8-Positive T-Lymphocytes - immunology | Urothelium - drug effects | Transforming Growth Factor beta - metabolism | Cohort Studies | Drug Resistance, Neoplasm - drug effects | PD-1 protein | CD8 antigen | Transforming growth factor-a | Antibodies | Parenchyma | Lymphocytes T | Metastasis | Immunity | Metastases | Genotype & phenotype | Signal transduction | Lymphocytes | Cell cycle | Fibroblasts | Growth factors | Urothelial cancer | Phenotypes | Cytokines | Melanoma | Blocking | Gene expression | Patients | Generalized linear models | Signaling | Stromal cells | Medical prognosis | Collagen | PD-L1 protein | Ligands | Determinants | Infiltration | Cancer | Tumors | Apoptosis | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 2934 - 2934
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 2676 - 2676
Journal Article
Cancer Discovery, ISSN 2159-8274, 02/2014, Volume 4, Issue 2, pp. 232 - 245
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2016, Volume 22, Issue 6, pp. 1499 - 1509
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2017, Volume 23, Issue 20, pp. 6138 - 6151
Purpose: FGFR1 amplification occurs in approximately 15% of estrogen receptor-positive (ER+) human breast cancers. Weinvestigated mechanisms by which FGFR1... 
AMPLIFICATION | PROTEIN | ONCOLOGY | THERAPEUTIC TARGET | GENES | ENDOCRINE THERAPY | FACTOR RECEPTOR-1 | FIBROBLAST-GROWTH-FACTOR | SIGNALING MODULE | EXPRESSION | NUCLEAR TRANSLOCATION | Humans | Gene Expression Regulation, Neoplastic | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Fibroblast Growth Factors - genetics | Molecular Targeted Therapy | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Breast Neoplasms - metabolism | Fibroblast Growth Factors - metabolism | Estrogen Receptor alpha - metabolism | Female | Transcription, Genetic | Disease Models, Animal | Estrogen Receptor alpha - antagonists & inhibitors | Breast Neoplasms - drug therapy | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Estrogen Receptor Modulators - pharmacology | Protein Transport | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Gene Amplification | Signal Transduction - drug effects | Breast Neoplasms - pathology | Cell Line, Tumor | Mice | Protein Kinase Inhibitors - pharmacology | Neoplasm Staging | Cell proliferation | Fibroblast growth factor | Transcription | Genes | Estrogens | Estrogen | Estrogen receptors | Antagonists | Kinases | Nuclei | Fulvestrant | Gene sequencing | E2F protein | Surgery | Xenografts | Inhibition | Fibroblast growth factor receptor 1 | Protein-tyrosine kinase | Deoxyribonucleic acid--DNA | Binding | Tyrosine | Deprivation | Breast cancer | siRNA | Gene expression | Patients | Polymerase chain reaction | Amplification | Ribonucleic acids | Experimental design | Breast | Ligands | Nuclei (cytology) | Tumors | Cancer | Fibroblast growth factor receptors | breast cancer | drug resistance | fulvestrant | FGFR1
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.